Treatment Resistant Depression

Steve Harvey, MD, discusses the challenges of defining treatment resistant depression and provides and overview of treatment options.

William M. Sauve, MD, reviews the landscape of delivery mechanisms for ketamine agents, including intravenous, sublingual, and intramuscular.

Hanita Chhabra, MD, highlights safety and efficacy data of esketamine and shares practical implications for clinical practice.

Geoffrey Grammer, MD, offers guidance on navigating challenges such as elevated blood pressure and substance misuse and abuse regarding the use of esketamine.